Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...

A North Carolina woman has filed a lawsuit in New Jersey federal court, claiming that her use of the diabetes medication ...

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...

Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma ...

Man arrested in North Carolina after roommate found fatally shot in Greenville ... What It Means for Eli Lilly, Novo Nordisk.

Policy shifts in Washington are rattling the economy, but North Carolina is poised for long-term success, says former ...

As a pioneer in diabetes care, Novo Nordisk NVO claims 34% of the USD 80 billion-plus diabetes treatment market and roughly half of the insulin market, itself worth more than USD 15 billion.

Novo Nordisk (NVO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire across the globe and make inroads into large markets like Brazil.

North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. Receive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to ...

North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. Receive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to ...